MAQ
Macquarie Technology Group Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💰 Dividends
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💰
2.17%
Annual dividend yield
Based on the most recent dividend
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
6
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Macquarie Telecom Group Ltd. engages in the provision of telecom and hosting services. The company is headquartered in Sydney, New South Wales and currently employs 446 full-time employees. The firm is engaged in the provision of telecommunication, cloud computing, cyber security and data center services to corporate and government customers within Australia. The firm operates through three segments: Telecom, Cloud Services and Government, and Data Centres. The Telecom segment relates to the provision of voice and mobile telecommunications services and the provision of services utilizing the Company’s data network. The Cloud Services & Government segment relates to the provision of services utilizing the Company’s data center facilities to provide cyber security, public and private cloud and storage to corporate and government customers. The Data Centres segment relates to the provision of services utilizing the Company’s data center facilities to wholesale customers.
📈 Performance
Price History
+760.17%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💰 Dividends
Payouts
💰 Annual Dividend Yield*
2.17%
💰 Annual Dividend Earnings Per $1,000 invested**
$21.75
💰 Most Recent Dividend Franked Percentage Estimate
100.00%
💰 Average Dividend Franked Percentage Estimate
100.00 %
💰 Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2025
$0.00
0.00%
2024
$0.00
0.00%
2023
$0.00
0.00%
2022
$0.00
0.00%
2021
$0.00
0.00%
2020
$0.00
0.00%
2019
$0.00
0.00%
2018
$0.50
100.00%
2017
$0.50
100.00%
2016
$0.50
100.00%
💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$61.33
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in MAQ
6
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in MAQ
722 days
MAQ investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
38%
50k - 100k
25%
Less than 50k
38%
👶 Age of investors
18 - 25
50%
26 - 34
33%
35 - 90
17%
🙋 Legal gender of investors
Female
17%
Male
83%
Pearlers who invest in MAQ also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
📊 Share price
$34.01 AUD
NULL US
NULL EX AUSTRALIA
NULL BETA
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
HACK.AX was created on 2016-08-30 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The fund aims to track the performance of an index (before fees and expenses) that provides exposure to the leading companies in the global cybersecurity sector.
📊 Share price
$9.18 AUD
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
📊 Share price
$104.08 AUD
NULL GLOBAL
NULL EX AUSTRALIA
NULL BETA
Want more shares? Try these...
Microba Life Sciences Ltd. analyzes the microbiome to discover novel therapeutics and develop new diagnostic tools. The company is headquartered in Brisbane, Queensland. The company went IPO on 2022-04-05. The firm is engaged in the discovery and development of therapeutics for major chronic diseases and delivers gut microbiome testing services globally to researchers, clinicians and consumers. The company offers a range of platforms, such as Analysis Platform, Discovery Platform and Therapeutic Platform. Through its analysis and discovery platforms, it identifies microbiome-derived therapeutics and diagnostic tools to advance medicine. The company provides precise and comprehensive measurements of the human gut microbiome. Through its Analysis Platform, it generates a global databank of microbiome samples and associated metadata to develop new health solutions. Its Discovery Platform enables partners to access this databank for the data-driven discovery of product opportunities. Its therapeutic platform is a repeatable platform for microbial therapeutic leads. The company has two segments: Testing Services, and Research & Development.
📊 Share price